SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001640455-20-000118
Filing Date
2020-10-29
Accepted
2020-10-29 16:16:35
Documents
1
Effectiveness Date
2020-10-29
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 13270
  Complete submission text file 0001640455-20-000118.txt   14379
Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 857-259-3840
Jounce Therapeutics, Inc. (Filer) CIK: 0001640455 (see all company filings)

IRS No.: 454870634 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-379231 | Film No.: 201272861
SIC: 2836 Biological Products, (No Diagnostic Substances)